your market intelligence analyst
Search Results
Edit Save
170,533 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
Business Wire 02/20/2020 10:00
COLUMBUS, Ohio--(BUSINESS WIRE)--Vertiv Holdings Co (NYSE: VRT), a global provider of critical digital infrastructure and continuity solutions, will report its fourth quarter and full year 2019 results prior to market open on Monday, March 9. Vertiv’s management team will discuss the results during a conference call the same day starting at 9:00 a.m. Eastern Time. A webcast of the live conference call will be available for interested parties to listen to by going to the Investor Relations secti.
PhoneArena 02/20/2020 09:58
Apple has always been running a tight ship when it comes to what users can and can’t do with their Apple devices. The company often defends its decisions by saying that they’re for the good of the users but most of the time it’s just looking after its own interests. A prime example are default apps on iOS. While you don’t have to use them, you can download the Firefox mobile browser, for example, Apple doesn’t let you ignore them completely. If you click a link in a text message, it will open in Safari, no questions asked. But it seems the tide has turned over at Cupertino. that ...
Lodging 02/20/2020 09:57
HENDERSONVILLE, Tenn. — The U.S. hotel industry reported positive results across three key performance metrics during January 2020, according to data from STR. Compared with January 2019, occupancy increased 0.8 percent to 55.1 percent, average daily rate (ADR) grew 1.4 percent to $126.06; and revenue per available room (RevPAR) jumped 2.2 percent to $69.47. “The industry opened 2020 with records across the key performance metrics and fairly substantial year-over-year growth when considering recent trends,” said […]. .
IET Knowledge Network 02/20/2020 09:57
Brexit ‘phase 1’ is done. Now to flesh out the nature of Britain’s relationship with Brussels before the ‘phase 2’ end-of-year deadline. All manner of trade, technology and energy issues will be affected, depending on whether the UK government insists on breaking with EU rules or sticks closely to them in return for lucrative unfettered market access. Emissions trading is one area where the two parties could come to blows and where the EU could deploy its latest protectionist trade tool. The UK is leaving the EU’s Emissions Trading Scheme (ETS) but intends to set up a similar system and even link them together if possible. However, if the prices do not match there will be problems, especially if the UK is indeed granted access to the single.
Les affaires ne sont plus aussi bonnes qu’auparavant pour les détaillants de produits pétroliers. Subhash Hurpaul, secrétaire de la Petrol Retailers Association (PRA), affirme que c’est ce qu’ont observé des détaillants de l’association. L’un des principaux facteurs est sans conteste la recrudescence de stations-service qui poussent comme des champignons à travers l’île, avec pour conséquence la réduction de la part du gâteau impartie à chaque détaillant. «On dénombre environ 150 points de vente de carburant dans tout le pays, dont une vingtaine de...
Rossiyskaya Gazeta (Russia) 02/20/2020 09:55
Авиакомпаниям не нужно будет получать лицензию на перевозку пассажиров и грузов, достаточно сертификата эксплуатанта. "РГ" публикует закон, вносящий изменения в Воздушный кодекс и соответствующий федеральный закон.
ENDPOINTS 02/20/2020 09:53
→ Another delay has blighted Heron Therapeutics ‘ quest to get its long-acting non-opioid painkiller for post-surgical analgesia on to the US market. The company, whose product is meant to rival Pacira’s J&J -partnered, long-acting post-op painkiller Exparel , was handed an last year after the FDA asked for more data relating to chemistry, manufacturing, and controls as well as non-clinical information. Now, the FDA has extended its decision date to due to several factors, such as an amendment to the resubmitted NDA as well as reviews of two other NDAs at the FDA division. Meanwhile, the contract manufacturing site used to manufacture the drug — HTX-011 — has been reinspected by the FDA with no Form 483 observations issued and with a recomm.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications